AiXin Life International, Inc. reported significant declines in both revenue and profitability for the third quarter and the first nine months of 2025, according to its latest 10-Q filing. For the three months ended September 30, 2025, the company generated total revenue of $301,979, a decrease of 68% from $936,406 in the same period of 2024. The nine-month revenue also fell sharply to $1,161,739, down 63% from $3,120,615 year-over-year. The company recorded a net loss of $340,461 for the third quarter, compared to a loss of $546,186 in the prior year, while the nine-month net loss increased to $1,413,674 from $1,326,569.
The decline in revenue was attributed to a downturn in economic conditions, which impacted marketing and promotional activities across various segments. Direct sales revenue plummeted by 87% to $13,735, while pharmacy sales dropped 94% to $16,933. Hotel revenue also decreased by 29% to $135,548, and manufacture and sales revenue fell by 64% to $135,763. The company noted that the convenience of online shopping and reduced consumer spending contributed to these declines.
Operationally, AiXin Life has seen a significant reduction in its customer base and engagement metrics. The company reported a working capital deficit of $6,765,269 as of September 30, 2025, and cash and cash equivalents decreased from $62,310 at the end of 2024 to $19,113. The company’s total assets also fell to $3,372,467 from $4,406,360 at the end of the previous fiscal year. The decrease in cash flow was primarily due to increased cash outflows from operating activities, which totaled $1,772,076 for the nine months ended September 30, 2025.
In terms of strategic developments, AiXin Life has focused on enhancing its liquidity through a plan that includes cost reductions and potential equity offerings. The company has also engaged in acquisitions in the health and nutritional sector, including the purchase of pharmacies and a hotel, which it aims to leverage for future growth. However, the company faces substantial doubt about its ability to continue as a going concern, as indicated by its ongoing losses and liquidity challenges.
Looking ahead, AiXin Life intends to explore additional opportunities in the healthcare market, including expanding its product line and acquiring more retail outlets. However, the company acknowledges that its ability to achieve profitability will depend on various factors, including market demand, competition, and effective management of its operations. The management's outlook remains cautious, emphasizing the need for successful execution of its liquidity plan to navigate the current economic landscape.
About AiXin Life International, Inc.
AiXin Life International, Inc. is a Colorado holding company operating primarily in China through subsidiaries. It develops, manufactures, markets, and sells premium health and wellness products, including traditional Chinese remedies, nutritional supplements, and functional foods. Serving China’s growing middle class, AiXin employs an omni-channel model combining pharmacies, direct marketing, online sales, and wholesale distribution. Its vertically integrated approach includes in-house R&D, manufacturing, and personalized customer support to differentiate in a competitive market.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.